Overview

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
0
Participant gender:
All
Summary
This study will evaluate the safety and efficacy of Triple Combination Therapy compared with Fixed Combination brimonidine tartrate/timolol ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Brimonidine Tartrate
Brimonidine Tartrate, Timolol Maleate Drug Combination
Ophthalmic Solutions
Pharmaceutical Solutions
Timolol
Criteria
Inclusion Criteria:

- Ocular hypertension or primary open-angle glaucoma in each eye

- Requires treatment with IOP-lowering medication in both eyes

Exclusion Criteria:

- Required chronic use of ocular medications during the study other than study
medication

- Use of any corticosteroids within 30 days

- History of any prior eye surgery, except for uncomplicated eye surgery performed more
than 6 months before the Screening visit

- Anticipated wearing of contact lenses during the study